Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Carbocisteine 250mg/5ml oral solution |
| BNF code | 0307000J0AAACAC |
| Virtual Therapeutic Moiety | Carbocisteine |
| Date identifier became valid | 25 Apr 2019 |
| Previous product identifier | 320938006 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 5.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | spoonful |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Carbocisteine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 50.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solution.oral |
| Dose Form | |
| Formulation | Oral solution |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Carbocisteine 250mg/5ml oral solution (A A H Pharmaceuticals Ltd) | |
| Carbocisteine 250mg/5ml oral solution (Accord-UK Ltd) | |
| Carbocisteine 250mg/5ml oral solution (Medihealth (Northern) Ltd) | |
| Carbocisteine 250mg/5ml oral solution (Typharm Ltd) | |
| Mucodyne 250mg/5ml syrup (Lexon (UK) Ltd) | |
| Mucodyne 250mg/5ml syrup (Sanofi) | |
| Mucodyne 250mg/5ml syrup (Sigma Pharmaceuticals Plc) | |
| Virtual Medicinal Product Packs | |
| Carbocisteine 250mg/5ml oral solution 125 ml | |
| Carbocisteine 250mg/5ml oral solution 250 ml | |
| Carbocisteine 250mg/5ml oral solution 300 ml | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.